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Avoiding Patient–Prosthesis Mismatch
Is TAVI a New Solution?*
William J. Stewart, MD, L. Leonardo Rodriguez, MD
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iConservation of mass is the principle behind the
continuity equation (1–3), used commonly for calcu-
lation of aortic valve area (AVA) in native aortic
stenosis and prosthetic valves. Utilizing 2-dimensional
echocardiographic and Doppler data, this equation is
the preferred technique to evaluate native and pros-
thetic valve stenosis. Although there is a body of
literature regarding surgically implanted aortic valve
replacements (sAVR), data on the hemodynamic pro-
file of the new transcatheter aortic valve implantation
(TAVI) technique are still scarce. The structure of
these valves differs significantly from sAVR, and may
offer hydrodynamic advantages for a subgroup of
patients.
See page 1053
Following nicely in the Hatle legacy (1), the
interesting study by Clavel et al. (4) in this issue
of iJACC used velocity and imaging data to
calculate the effective valve orifice area by Dopp-
ler echocardiography in patients after TAVI.
They compared 2 methods of calculating AVA
and found it to be preferable to measure the left
ventricular outflow tract (LVOT) diameter proxi-
mal to, rather than within, the prosthesis stent.
This method was superior because it correlated
better with the gradient data (based on the simpli-
fied Bernoulli equation) and had lower interob-
server and intraobserver variation.
The methodology may seem self-evident. It
makes sense to measure the annular diameter in the
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contents of this paper to disclose.ame location where the pulsed Doppler velocity
as measured, with the sample volume 0.5 to 1.0
m below the leaflets of the TAVI. However, their
aper underlines the importance of exacting meth-
dology and also illustrates again the hemodynamic
dvantages of TAVI.
Four questions arise from the data presented by
lavel et al. (4):
. Is it accurate to measure AVA with Doppler
echocardiography in patients with TAVI?
. Does the size of the prosthesis make a difference
in outcome?
. Do aortic valve area index (AVAI) measure-
ments differ between TAVI and AVR?
. How should the AVAI calculations after TAVI
or AVR affect our decisions in management of
patients presenting with native aortic stenosis?
ethods of measuring AVAI in prosthetic valves, a tale
f apples and oranges. Continuous-wave Doppler
an be used to derive prosthetic valve gradients, but
he results are often higher than invasively derived
radients. Because normal and stenotic prostheses are
ifficult or dangerous to cross, with some perceived
isk of valve damage, catheter gradients in prosthetic
alves are difficult to record optimally. Invasive aortic
alve gradients (AVG) in most catheterization labo-
atories are peak-to-peak gradients recorded from
ullback of 1 catheter across the aortic valve (5), a far
ifferent entity than the peak instantaneous gradient,
hich is the one to which the peak velocity obtained
y continuous-wave Doppler is equivalent. In addi-
ion, the “pressure recovery” phenomenon, also called
he “airplane wing” effect (6,7), causes the aortic
ressure to rise within a few centimeters down-
tream of its low point immediately above the valve.
oppler, therefore, records a higher valvular veloc-
ty and derives a higher maximum gradient than
ould be obtained by the ideal invasive pressure
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1064recording, which would be a dual transducer set-up,
with a multiholed catheter in the left ventricle (LV)
derived by a trans-septal approach, and another in
the aorta very close to the aortic side of the
prosthesis. Discrepancies based on pressure recov-
ery are more pronounced in smaller prosthetic
valves with high flow (8). Calculation of AVA in
prosthetic valves by the continuity equation takes
into consideration the upstream velocity and diam-
eter measurements, the site of which are of critical
importance, as demonstrated by Clavel et al. (4).
Doppler-derived measurements are plainly the
method of choice because of their noninvasive
nature, reproducibility, and clinical importance.
Though changes in cardiac output and heart rate
still cause some variability, Doppler-derived AVA
measurements are useful for comparing the function
of a patient’s prosthesis with others of the same type
and size, and in comparison with the patient’s own
baseline recordings done on earlier visits.
Prosthetic AVA in sAVR is easy to calculate by
Doppler and is reproducible. However, it has been
underutilized, partly because the data obtained,
even in a normal newly implanted AVR, are often
unsettling. Although it has long been recognized
that prosthetic valves are inherently stenotic, the
degree of this stenosis is often surprising. The high
maximum velocities often cause a low calculated
AVA. Particularly in the case of small-size (19 or 21
mm) prostheses, the AVA is often not much higher
and AVG is not much lower than that obtained on
the patient’s native stenotic valve prior to surgery.
Thus, many echocardiographic laboratories have
been reluctant to report AVA in patients with
sAVR. Reproducibility of measurements, of practi-
cal importance when AVA is used for serial follow-
up, is shown to be good in the current study from
Clavel et al. (4).
In prosthetic valves, size matters. Numerous pub-
lished series of patients with sAVR have found a
to a Stented Aortic Prosthesis in Patients at Risk for PPM
Potential Disadvantages
Increased surgical difﬁculty and periop risk
Involves root surgery  coronary reimplantation
Increased surgical difﬁculty and periop risk
Involves root surgery  coronary re-implantation
Calciﬁed aortic root hinders reop surgery later
ortic root
at initial
Increased surgical difﬁculty and periop risk
More heart block, pacemakers
Increased regurgitation, strokes
Uncertain long-term durability
ement; periop  perioperative; PPM  patient–prosthesis mismatch; reop 
atheter aortic valve implantation.substantial effect on outcome of valve area indexed
by body surface area (BSA), abbreviated as AVAI.
In particular, adverse clinical outcomes have been
found for patients with small aortic annular diam-
eter, large body surface area, poor LV function, and
higher cardiac output requirements. Patients with
sAVR whose post-operative AVAI is 0.65
cm2/m2 have been considered to have severe “pa-
tient–prosthesis mismatch” (PPM), which is asso-
ciated with decreased survival, increased complica-
tions, and less regression in LV hypertrophy,
compared with those with higher AVAI (9–15).
The American Society of Echocardiography recom-
mends predicting the risk of PPM pre-operatively
(16). Based on the patient’s annular size, reference
data on AVA for whichever type of surgical pros-
thesis is anticipated, and the patient’s BSA, the
expected AVAI can be easily predicted. When that
predicted AVAI is low, alternative options should
be considered, though each has advantages and
disadvantages (Table 1).
Some research concludes that prosthesis size after
sAVR does not affect outcome significantly. Using
the manufacturer’s stated size, and following large
groups of patients with various valve sizes over time,
Blackstone et al. (17) and Koch et al. (18) found no
differences in outcome between prosthetic valve
sizes.
The hemodynamics of TAVI are better than sAVR. In
lavel et al. (4), the average effective AVA (not
ndexed) for a patient with an aortic annulus of
9-mm diameter having TAVI was 1.37 cm2,
whereas the average post-operative effective AVA
of 19-mm sAVR valves, according to previous
publications, averages 1.1 cm2 (13). In a sample
patient with a BSA of 1.7 m2, the AVAI after
AVR with a 19-mm stented bioprosthesis would
ikely be 0.65 cm2/m2, representing severe PPM. If
the same patient was treated with TAVI, the AVAI
would be 0.81 cm2/m2, which is in the high
moderate, almost mild range of PPM, at much
lower risk of adverse outcomes.
The better hemodynamics of TAVI are consis-
tent with data from cohort A of the PARTNER
(Placement of AoRTic TraNscathetER Valve) trial,
recently presented by Smith et al. (19). Among all
patients randomized to TAVI, including prostheses
of all sizes, the AVA estimated by Doppler 1 year
after the procedures averaged 1.6 cm2, higher than
he mean AVA in patients randomized to sAVR,
hich was 1.4 cm2. Similarly, including prostheses
of all sizes, patients randomized to TAVI had aTable 1. Alternatives
Procedure
Stentless bioprosthesis
AVR homograft
Stented AVR with an a
widening procedure
operation
TAVI
AVR  aortic valve replacmean AVG of 10.2 mm Hg, significantly lower
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1065than those randomized to sAVR, in whom the
mean AVG was 11.5 mm Hg (19).
A previous article, also first authored by Clavel
(20), compared the gradients and AVAI of patients
with TAVI or sAVR, in groups matched for gen-
der, aortic annulus diameter, LV ejection fraction,
BSA, and body mass index. In that study, similar to
the aforementioned trial, TAVI patients had better
hemodynamics than sAVR, with smaller average
gradients (10 mm Hg vs. 13 mm Hg) and larger
AVAI (1.50 cm2/m2 vs. 1.33 cm2/m2), averaging all
valve sizes.
The finding of larger AVA and lower AVG after
TAVI compared with sAVR may reflect less mate-
rial between the valve orifice and the patient’s
annulus. On the other hand, this finding is surpris-
ing, because the process of TAVI does not involve
removal of the native aortic leaflets, as occurs in
sAVR, which could theoretically influence AVA in
the opposite direction.
Optimal management of patients with aortic stenosis
and small aortic annulus diameter based on predicted
AVAI. The improvement in hemodynamics of
TAVI over sAVR, though small, may be suffi-
cient to reduce the risks of adverse cardiac events,
if the long-term outcome of TAVI follows what
has been published comparing different sizes of
Figure 1. Incidence of Severe PPM in the 3 Aortic Bioprosthesis
Prosthesis–patient mismatch (PPM) is shown at hospital discharge a
aortic valve implantation (PAVI) is indicated by the green bars. Sur
the yellow bars. Surgical aortic valve replacement–stented valve (S
from Clavel et al. (20).sAVR.In the article published in this issue by Clavel et
al. (4), patients treated with TAVI showed a lower
incidence of PPM (9%) than the 20% to 80%
incidence in similar reported populations of surgical
AVR with severe native aortic stenosis and similar
annulus size (10–13). In the previously mentioned
study of matched sAVR and TAVI groups, also by
Clavel et al. (20), there was also a lower incidence of
PPM (6%) compared with the sAVR group (28%)
(Fig. 1).
TAVI also has some disadvantages, including a
higher incidence of moderate or severe regurgita-
tion (7.1% at 1 year vs. 1.9% for sAVR), especially
periprosthetic leaks (19), which is unclear in its
clinical significance (21). TAVI also had a higher
risk of stroke or vascular trauma than sAVR in the
PARTNER A data. On the other hand, greater
bleeding and atrial fibrillation are reported in sAVR
than in TAVI (19).
Conclusions
The Doppler echocardiographic methodology for
measuring AVAI in percutaneous valves is able to
achieve reproducible results that will help in com-
paring the hemodynamic effects of TAVI with
various types of surgical valve prostheses. Neglected
for many years, the problem of PPM is like putting
ups
at follow-up according to the aortic annulus size. Percutaneous
l aortic valve replacement–stentless valve (SAVR-SL) is indicated by
-ST) is indicated by the pink bars. Reproduced, with permission,Gro
nd
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AVRa small nozzle on the end of a large-diameter fire
a
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1066hose. Especially in patients with small aortic annu-
lar size, there are important and avoidable risks.
Though not perfect, TAVI represents a new option
to solve this dilemma. Proactive decisions between
the choices listed in Table 1 should be considered.
Although no published data document the clinical
outcome of TAVI in patients who would haveMedtronic-Hall, Starr-Edwards, and
1
1
1
1
1
1
longterm survivalmethodology of Clavel et al. (4) may help to answer
these important clinical questions.
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